TrialAdvances in therapy2024

Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration Beyond One Year of Treatment: AZURE, a Randomized Trial of Treat-and-Extend vs. Fixed Dosing.

Laurent Kodjikian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.